1. U.S. Patent Office Accepts Pfizer’s Reissue Application on Lipitor Enantiomer Patent
01-07-2009
Pfizer announced that the U.S. Patent & Trademark Office has issued a “Notice of Allowance” accepting the company’s application to correct the technical defect in the ‘995 enantiomer patent for atorvastatin calcium, the salt form of ...
2. FDA to Review Daiichi Sankyo, Lilly Drug Prasugrel
01-06-2009
Daiichi Sankyo and Eli Lilly confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) will review prasugrel during an advisory committee hearing on February 3, 2009. Prasugrel ...
3. DAIICHI SANKYO records loss on investment in Ranbaxy Laboratories
01-06-2009
Daiichi Sankyo announced that it plans to record a valuation loss and one-time write-down of goodwill on its investment in Group subsidiary Ranbaxy Laboratories Limited for the fiscal third-quarter ended December 31, 2008.
On ...
4. China Nepstar Chain Drugstore Announces New Management Team Members
01-06-2009
China Nepstar Chain Drugstore announced the appointment of Mr. Ian Wade the Co-Chief Executive Officer. Concurrently, the Company announced the appointment of Mr. William Weili Dai as the new Chief Financial Officer. Both appointments will be ...
5. FDA approved 99 original new drug applications
01-05-2009
FDA approved 99 original new drug applications in 2008. Abbott, Akorn, AstraZeneca, Aurobindo Pharma, and UCB Inc. top the list with three or more approvals. 22 applications are Type 1, i.e.new molecular entity; 4 are Type 2, i.e. ...
6. Novartis to license AlphaVax' investigational CMV vaccine program
12-29-2008
Novartis has reached an exclusive agreement to license AlphaVax' investigational Cytomegalovirus (CMV) vaccine program. This CMV agreement adds to Novartis' early stage pipeline of novel vaccines, which focuses on the prevention of fatal diseases ...
7. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals
12-29-2008
Johnson & Johnson announced that stockholders of Omrix Biopharmaceuticals tendered approximately 16,749,152 shares of Omrix common stock representing approximately 97.8% of Omrix's outstanding common stock.
Johnson & Johnson ...
8. Daiichi Sankyo Enters Alliance with The Kitasato Institute
12-26-2008
Daiichi Sankyo announced that it has signed a master agreement for an alliance with The Kitasato Institute for research, development, manufacturing and marketing of human vaccines for the prevention and treatment of infectious diseases in ...
9. Bradley E. Lerman Joins Pfizer as Senior Vice President of Litigation
12-23-2008
Pfizer Inc announced that Bradley E. Lerman will join the company as Senior Vice President, Litigation. Mr. Lerman, who will be responsible for leading the company’s litigation efforts, will report to Senior Vice President and General Counsel ...
10. Beijing Institute of Genomics selects Life Technologies' SOLiD System
12-23-2008
Life Technologies announced through its Applied Biosystems unit, that the Beijing Institute of Genomics (BIG) of the Chinese Academy of Sciences has acquired 8 additional SOLiD(TM) Systems. The SOLiD System is a genomic analysis platform ...
[1] ...